Allworth Financial LP Denali Therapeutics Inc. Transaction History

Allworth Financial LP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 23, 2024	SELL	$14.96 - $23.22 $329 - $510	-22 Reduced 25.58%	64 $1,000
Q1 2024 Apr 25, 2024	SELL	$15.83 - $23.35 $12,711 - $18,750	-803 Reduced 90.33%	86 $1,000
Q4 2023 Jan 24, 2024	BUY	$16.2 - $23.18 $13,608 - $19,471	840 Added 1714.29%	889 $19,000
Q3 2023 Oct 31, 2023	BUY	$20.63 - $30.17 $1,010 - $1,478	49 New	49 $1,000
Q2 2022 Jul 13, 2022	BUY	$20.88 - $35.19 $167 - $281	8 New	8 $0

227

119M

60.6K

48.4K

Ticker DNLI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 134,174,000
Market Cap $2.88B
Description
Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.